Loading...
BioGaia AB (publ)
BIOGY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.75
$-0.40(-3.99%)
BioGaia AB (publ) (BIOGY) Financial Performance & Statements
Review BioGaia AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.73%
↑ 9.73%
Operating Income Growth
-4.45%
↓ 4.45%
Net Income Growth
-3.82%
↓ 3.82%
Operating Cash Flow Growth
-12.38%
↓ 12.38%
Operating Margin
26.59%
↑ 26.59%
Gross Margin
72.81%
↑ 72.81%
Net Profit Margin
21.83%
↑ 21.83%
ROE
18.50%
↑ 18.50%
ROIC
20.05%
↑ 20.05%
BioGaia AB (publ) (BIOGY) Financial Statements
Explore quarterly and annual reports for BioGaia AB (publ) stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $366.26M | $364.83M | $303.97M | $384.12M |
| Cost of Revenue | $97.90M | $106.29M | $81.64M | $100.08M |
| Gross Profit | $268.36M | $258.54M | $222.34M | $284.04M |
| Gross Profit Ratio | $0.73 | $0.71 | $0.73 | $0.74 |
| R&D Expenses | $22.67M | $33.77M | $71.39M | $26.83M |
| SG&A Expenses | $124.19M | $133.57M | $104.77M | $116.03M |
| Operating Expenses | $171.23M | $155.15M | $180.91M | $142.86M |
| Total Costs & Expenses | $269.13M | $261.44M | $262.55M | $242.94M |
| Interest Income | $6.88M | $10.71M | $7.85M | $8.86M |
| Interest Expense | $2.10M | $9.61M | $2.29M | $1.48M |
| Depreciation & Amortization | $6.20M | $7.26M | $57.55M | $6.15M |
| EBITDA | $110.22M | $121.35M | $106.82M | $147.33M |
| EBITDA Ratio | $0.30 | $0.33 | $0.35 | $0.38 |
| Operating Income | $97.14M | $103.39M | $41.42M | $141.18M |
| Operating Income Ratio | $0.27 | $0.28 | $0.14 | $0.37 |
| Other Income/Expenses (Net) | $4.78M | $1.10M | $5.56M | $7.38M |
| Income Before Tax | $101.91M | $104.49M | $46.98M | $142.75M |
| Income Before Tax Ratio | $0.28 | $0.29 | $0.15 | $0.37 |
| Income Tax Expense | $21.71M | $22.56M | $10.38M | $31.74M |
| Net Income | $80.20M | $81.93M | $36.60M | $111.01M |
| Net Income Ratio | $0.22 | $0.22 | $0.12 | $0.29 |
| EPS | $0.79 | $0.81 | $0.36 | $1.10 |
| Diluted EPS | $0.79 | $0.81 | $0.36 | $1.10 |
| Weighted Avg Shares Outstanding | $101.16M | $101.16M | $101.16M | $100.98M |
| Weighted Avg Shares Outstanding (Diluted) | $101.16M | $101.16M | $101.16M | $101.004M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan